Osprey Medical

About:

Osprey Medical develops and commercializes its propriety CINCOR™ System designed for the prevention of contrast induced mephropathy.

Website: http://ospreymed.com

Twitter/X: MedOsprey

Top Investors: Canaccord Genuity Group, Bell Potter, Allan Gray, Bill Potter

Description:

Osprey Medical is a medical device company incorporated in 2005 with operations based Minnetonka, Minnesota, USA. The Company is focused on the development and commercialization of its propriety CINCOR™ System designed for the prevention of Contrast Induced Nephropathy (CIN). The CINCOR™ System originated from technology developed at the Baker Heart and Diabetes Institute in Melbourne, Australia.

Total Funding Amount:

$97.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Minnetonka, Minnesota, United States

Founded Date:

2005-01-01

Contact Email:

customerservice(AT)ospreymed.com

Founders:

J. Edward Shapland

Number of Employees:

11-50

Last Funding Date:

2018-11-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai